18 results on '"de Araújo DP"'
Search Results
2. Volumetric alterations in the basal ganglia in autism Spectrum disorder: A systematic review.
- Author
-
de Medeiros Marcos GVT, Feitosa DDM, Paiva KM, Oliveira RF, da Rocha GS, de Medeiros Guerra LM, de Araújo DP, Goes HM, Costa S, de Oliveira LC, Guzen FP, de Souza Júnior JE, de Moura Freire MA, de Aquino ACQ, de Gois Morais PLA, and de Paiva Cavalcanti JRL
- Subjects
- Humans, Autism Spectrum Disorder diagnostic imaging, Autism Spectrum Disorder pathology, Autism Spectrum Disorder physiopathology, Basal Ganglia pathology, Basal Ganglia diagnostic imaging
- Abstract
Introduction: Recent research indicates that some brain structures show alterations in conditions such as Autism Spectrum Disorder (ASD). Among them, are the basal ganglia that are involved in motor, cognitive and behavioral neural circuits., Objective: Review the literature that describes possible volumetric alterations in the basal ganglia of individuals with ASD and the impacts that these changes have on the severity of the condition., Methodology: This systematic review was registered in the design and reported according to the PRISMA Items and registered in PROSPERO (CRD42023394787). The study analyzed data from published clinical, case-contemplate, and cohort trials. The following databases were consulted: PubMed, Embase, Scopus, and Cochrane Central Register of Controlled Trials, using the Medical Subject Titles (MeSH) "Autism Spectrum Disorder" and "Basal Ganglia". The last search was carried out on February 28, 2023., Results: Thirty-five eligible articles were collected, analyzed, and grouped according to the levels of alterations., Conclusion: The present study showed important volumetric alterations in the basal ganglia in ASD. However, the examined studies have methodological weaknesses that do not allow generalization and correlation with ASD manifestations., (© 2024 International Society for Developmental Neuroscience.)
- Published
- 2024
- Full Text
- View/download PDF
3. Virtual Patients: Impact of Computer Simulation on Audiology Learning and Practice.
- Author
-
de Araújo DP, Duarte JL, and Araújo ES
- Subjects
- Humans, Computer Simulation, Prospective Studies, Learning, Students, Audiology
- Abstract
Purpose: The purpose of this study was to verify users' satisfaction with the interface of an audiometric simulator and self-perception of the computer simulation impact on practical acting in audiology, allowing the identification of problems and possibilities for improvement., Method: A prospective, observational study was divided into two phases: The first is evaluating the student's satisfaction, using the simulator in the theoretical and practical learning of audiology, and the second one is assessing the self-perception of the simulator's impact on the practical performance of audiology. The sample comprised 35 students from two Speech-Language Pathology and Audiology courses, in Brazil, selected by convenience, who answered the questionnaire after completing the theoretical module, using Google Forms, without any identification., Results: In the first phase of the study, students positively evaluated the use of the simulator as an auxiliary tool for audiology learning, and in the second one, they also positively assessed the impact of training with the simulator in audiological practice., Conclusion: The analyzed audiometric simulator proved to be an interactive system with high acceptability, level of satisfaction, and potential impact on practical performance in audiology., Supplemental Material: https://doi.org/10.23641/asha.23876325.
- Published
- 2023
- Full Text
- View/download PDF
4. Neurobiological effects of forced swim exercise on the rodent hippocampus: a systematic review.
- Author
-
Oliveira RF, Paiva KM, da Rocha GS, de Moura Freire MA, de Araújo DP, de Oliveira LC, Guzen FP, de Gois Morais PLA, and de Paiva Cavalcanti JRL
- Subjects
- Animals, Rodentia, Time Factors, Antioxidants metabolism, Hippocampus physiology, Physical Conditioning, Animal physiology, Swimming physiology
- Abstract
Forced swimming is a common exercise method used for its low cost and easy management, as seen in studies with the hippocampus. Since it is applied for varied research purposes many protocols are available with diverse aspects of physical intensity, time and periodicity, which produces variable outcomes. In the present study, we performed a systematic review to stress the neurobiological effects of forced swim exercise on the rodent hippocampus. Behavior, antioxidant levels, neurotrophins and inflammatory markers were the main topics examined upon the swimming effects. Better results among these analyses were associated with forced exercise at moderate intensity with an adaptation period and the opposite for continuous exhausting exercises with no adaptation. On further consideration, a standard swimming protocol is necessary to reduce variability of results for each scenario investigated about the impact of the forced swimming on the hippocampus., Forced swimming is a common exercise method used for its low cost and easy management, as seen in studies with the hippocampus. Since it is applied for varied research purposes many protocols are available with diverse aspects of physical intensity, time and periodicity, which produces variable outcomes. In the present study, we performed a systematic review to stress the neurobiological effects of forced swim exercise on the rodent hippocampus. Behavior, antioxidant levels, neurotrophins and inflammatory markers were the main topics examined upon the swimming effects. Better results among these analyses were associated with forced exercise at moderate intensity with an adaptation period and the opposite for continuous exhausting exercises with no adaptation. On further consideration, a standard swimming protocol is necessary to reduce variability of results for each scenario investigated about the impact of the forced swimming on the hippocampus.
- Published
- 2021
- Full Text
- View/download PDF
5. L-linalool exerts a neuroprotective action on hemiparkinsonian rats.
- Author
-
de Lucena JD, Gadelha-Filho CVJ, da Costa RO, de Araújo DP, Lima FAV, Neves KRT, and de Barros Viana GS
- Subjects
- Acyclic Monoterpenes therapeutic use, Animals, Apomorphine pharmacology, Brain drug effects, Brain metabolism, Disease Models, Animal, Dopamine metabolism, Lipid Peroxidation drug effects, Male, Motor Activity drug effects, Oxidopamine, Parkinson Disease metabolism, Rats, Rats, Wistar, Acyclic Monoterpenes pharmacology, Neuroprotective Agents pharmacology, Parkinson Disease drug therapy
- Abstract
Linalool (LIN) is a monoterpene, responsible for the aroma of essential oils in some species. It presents a sedative and anxiolytic potential, enhancing GABAergic currents and behaving as a benzodiazepine-type of drug. The objectives of the present work were to study the neuroprotective effects of LIN on a model of Parkinson's disease. For that, male Wistar rats were divided into the following groups: sham-operated (SO), 6-OHDA-lesioned, and 6-OHDA-lesioned and treated with LIN (25, 50, and 100 mg/kg, p.o.) for 2 weeks. Afterwards, the animals were subjected to behavioral tests (apomorphine-induced rotations, open field, and forced swimming tests). Then, the animals were euthanized, and the striatum, hippocampus, and prefrontal cortex were processed for neurochemistry (nitrite and lipoperoxidation measurements) and immunohistochemistry (TH and DAT) assays. The results were analyzed by ANOVA and Tukey's test for multiple comparisons and considered significant at p < 0.05. LIN significantly improved the behavioral alterations of the 6-OHDA-lesioned group, as evaluated by the apomorphine-induced rotations, open field, and forced swimming tests. In addition, LIN partially reversed the decreased DA, DOPAC, and HVA contents observed in the 6-OHDA-lesioned striatum. The untreated 6-OHDA group presented increased nitrite contents and lipoperoxidation in all the brain areas studied, and these changes were completely reversed after LIN treatments. Finally, LIN significantly prevented the reduction in TH and DAT expressions demonstrated in the right 6-OHDA-lesioned striatum. All these data strongly suggest that LIN presents a neuroprotective action in hemiparkinsonian rats, probably related to the drug anti-inflammatory and antioxidant activities.
- Published
- 2020
- Full Text
- View/download PDF
6. Haloperidol-Induced Preclinical Tardive Dyskinesia Model in Rats.
- Author
-
Guzen FP, Cavalcanti JRLP, Cavalcanti DMLP, de Sales LGP, da Silva MSM, da Silva ANA, Pinheiro FI, and de Araújo DP
- Subjects
- Animals, Drug Evaluation, Preclinical methods, Male, Mastication physiology, Rats, Rats, Wistar, Tardive Dyskinesia physiopathology, Antipsychotic Agents toxicity, Disease Models, Animal, Haloperidol toxicity, Mastication drug effects, Tardive Dyskinesia chemically induced
- Abstract
Haloperidol is a first-generation antipsychotic used in the treatment of psychoses, especially schizophrenia. This drug acts by blocking dopamine D2 receptors, reducing psychotic symptoms. Notwithstanding its benefits, haloperidol also produces undesirable impacts, in particular extrapyramidal effects such as tardive dyskinesia (TD), which limit the use of this and related drugs. TD is characterized by repetitive involuntary movements occurring after chronic exposure therapy with haloperidol. Symptoms most commonly manifest in the orofacial area and include involuntary movements, tongue protrusion, pouting lips, chewing in the absence of any object to chew, and facial grimacing. The most serious aspect of TD is that it may persist for months or years after drug withdrawal and is irreversible in some patients. This unit, aimed at facilitating the study of TD, describes methods to induce TD in rats using haloperidol, as well as procedures for evaluating the animals's TD-related symptoms. © 2019 by John Wiley & Sons, Inc., (© 2019 John Wiley & Sons, Inc.)
- Published
- 2019
- Full Text
- View/download PDF
7. Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer's Disease: A Systematic Review.
- Author
-
da Costa IM, Freire MAM, de Paiva Cavalcanti JRL, de Araújo DP, Norrara B, Moreira Rosa IMM, de Azevedo EP, do Rego ACM, Filho IA, and Guzen FP
- Subjects
- Alzheimer Disease metabolism, Alzheimer Disease pathology, Alzheimer Disease prevention & control, Amyloid beta-Peptides metabolism, Animals, Curcuma chemistry, Curcumin pharmacology, Dietary Supplements, Humans, Neurofibrillary Tangles metabolism, Neuroprotective Agents pharmacology, Plant Extracts pharmacology, Randomized Controlled Trials as Topic, Alzheimer Disease drug therapy, Curcumin administration & dosage, Neuroprotective Agents administration & dosage, Plant Extracts administration & dosage
- Abstract
Background: The formation of senile plaques and neurofibrillary tangles of the tau protein are the main pathological mechanism of Alzheimer's disease (AD). Current therapies for AD offer discrete benefits to the clinical symptoms and do not prevent the continuing degeneration of neuronal cells. Therefore, novel therapeutic strategies have long been investigated, where curcumin (Curcuma longa) has shown some properties that can prevent the deleterious processes involved in neurodegenerative diseases., Objective: The aim of the present work is to review studies that addressed the effects of curcumin in experimental models (in vivo and in vitro) for AD., Method: This study is a systematic review conducted between January and June 2017, in which a consultation of scientific articles from indexed periodicals was carried out in Science Direct, United States National Library of Medicine (PubMed), Cochrane Library and Scielo databases, using the following descriptors: "Curcuma longa", "Curcumin" and "Alzheimer's disease"., Results: A total of 32 studies were analyzed, which indicated that curcumin supplementation reverses neurotoxic and behavioral damages in both in vivo and in vitro models of AD., Conclusion: The administration of curcumin in experimental models seems to be a promising approach in AD, even though it is suggested that additional studies must be conducted using distinct doses and through other routes of administration., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2019
- Full Text
- View/download PDF
8. Aspidosperma pyrifolium Mart: neuroprotective, antioxidant and anti-inflammatory effects in a Parkinson's disease model in rats.
- Author
-
de Araújo DP, Nogueira PCN, Santos ADC, Costa RO, de Lucena JD, Jataí Gadelha-Filho CV, Lima FAV, Neves KRT, Leal LKAM, Silveira ER, and Viana GSB
- Subjects
- Animals, Behavior, Animal drug effects, Corpus Striatum metabolism, Disease Models, Animal, Dopamine metabolism, Dopamine Plasma Membrane Transport Proteins metabolism, Lipid Peroxidation drug effects, Male, Nitrites metabolism, Oxidopamine metabolism, Plant Extracts chemistry, Rats, Seeds chemistry, Tumor Necrosis Factor-alpha metabolism, Tyrosine 3-Monooxygenase metabolism, Anti-Inflammatory Agents pharmacology, Antioxidants pharmacology, Aspidosperma chemistry, Neuroprotective Agents pharmacology, Parkinson Disease drug therapy, Plant Extracts pharmacology
- Abstract
Objectives: Aspidosperma species are used for several diseases, especially for malaria in Brazil. Although the genus is object of pharmacological studies, almost none are found on Aspidosperma pyrifolium. We investigate neuroprotective, antioxidant and anti-inflammatory properties of the APSE-Aq fraction (benzoic acid glycosylated derivative) on Parkinson's disease model., Methods: Male Wistar rats were subjected to a 6-hydroxydopamine injection into the right striatum and treated or not with APSE-Aq (100 or 200 mg/kg, p.o.). The sham-operated group was injected with saline. Two weeks later, animals were subjected to behavioural, neurochemical and immunohistochemical evaluation. The data were analysed by ANOVA and Tukey test., Key Findings: The APSE-Aq-treated group shows a partial recovery of behavioural changes as compared with the untreated-6-hydroxydopamine group. A partial recovery was also observed in nitrite contents and lipid peroxidation. APSE-Aq treatments significantly reversed decreases in striatal dopamine and metabolites in the untreated 6-hydroxydopamine group. Immunostainings for markers as tyrosine hydroxylase and dopamine transporter decreased in the untreated 6-hydroxydopamine group and values recovered after APSE-Aq treatments. Similar data were seen for TNF-alpha., Conclusion: APSE-Aq presents neuroprotective, antioxidant and anti-inflammatory activities. Considering that APSE-Aq is chemically related to salicylic acid, it may act on similar targets., (© 2018 Royal Pharmaceutical Society.)
- Published
- 2018
- Full Text
- View/download PDF
9. Corrigendum to "The Treadmill Exercise Protects against Dopaminergic Neuron Loss and Brain Oxidative Stress in Parkinsonian Rats".
- Author
-
da Costa RO, Gadelha-Filho CVJ, da Costa AEM, Feitosa ML, de Araújo DP, de Lucena JD, de Aquino PEA, Lima FAV, Neves KRT, and de Barros Viana GS
- Abstract
[This corrects the article DOI: 10.1155/2017/2138169.].
- Published
- 2018
- Full Text
- View/download PDF
10. Behavioral and neurochemical effects of alpha lipoic acid associated with omega-3 in tardive dyskinesia induced by chronic haloperidol in rats.
- Author
-
de Araújo DP, Camboim TGM, Silva APM, Silva CDF, de Sousa RC, Barbosa MDA, Oliveira LC, Cavalcanti JRLP, Lucena EES, and Guzen FP
- Subjects
- Animals, Drug Interactions, Fatty Acids, Omega-3 therapeutic use, Lipid Peroxidation drug effects, Male, Neurochemistry, Oxidative Stress drug effects, Rats, Rats, Wistar, Tardive Dyskinesia chemically induced, Thiobarbituric Acid Reactive Substances metabolism, Thioctic Acid therapeutic use, Behavior, Animal drug effects, Fatty Acids, Omega-3 pharmacology, Haloperidol adverse effects, Tardive Dyskinesia drug therapy, Tardive Dyskinesia metabolism, Thioctic Acid pharmacology
- Abstract
Tardive dyskinesia (TD) is characterized by involuntary movements of the lower portion of the face being related to typical antipsychotic therapy. TD is associated with the oxidative imbalance in the basal ganglia. Lipoic acid (LA) and omega-3 (ω-3) are antioxidants acting as enzyme cofactors, regenerating antioxidant enzymes. This study aimed to investigate behavioral and neurochemical effects of supplementation with LA (100 mg/kg) and ω-3 (1 g/kg) in the treatment of TD induced by chronic use of haloperidol (HAL) (1 mg/kg) in rats. Wistar male rats were used, weighing between 180-200 g. The animals were treated chronically (31 days) with LA alone or associated with HAL or ω-3. Motor behavior was assessed by open-field test, the catalepsy test, and evaluation of orofacial dyskinesia. Oxidative stress was accessed by determination of lipid peroxidation and concentration of nitrite. LA and ω-3 alone or associated caused an improvement in motor performance by increasing locomotor activity in the open-field test and decreased the permanence time on the bar in the catalepsy test and decreased the orofacial dyskinesia. LA and ω-3 showed antioxidant effects, decreasing lipid peroxidation and nitrite levels. Thus, the use of LA associated with ω-3 reduced the extrapyramidal effects produced by chronic use of HAL.
- Published
- 2017
- Full Text
- View/download PDF
11. The Treadmill Exercise Protects against Dopaminergic Neuron Loss and Brain Oxidative Stress in Parkinsonian Rats.
- Author
-
da Costa RO, Gadelha-Filho CVJ, da Costa AEM, Feitosa ML, de Araújo DP, de Lucena JD, de Aquino PEA, Lima FAV, Neves KRT, and de Barros Viana GS
- Subjects
- Animals, Humans, Male, Oxidative Stress, Rats, Rats, Wistar, Brain pathology, Dopaminergic Neurons metabolism, Exercise Test methods, Parkinson Disease therapy
- Abstract
Parkinson's disease (PD), a progressive neurological pathology, presents motor and nonmotor impairments. The objectives were to support data on exercise benefits to PD. Male Wistar rats were distributed into sham-operated (SO) and 6-OHDA-lesioned, both groups without and with exercise. The animals were subjected to treadmill exercises (14 days), 24 h after the stereotaxic surgery and striatal 6-OHDA injection. Those from no-exercise groups stayed on the treadmill for the same period and, afterwards, were subjected to behavioral tests and euthanized for neurochemical and immunohistochemical assays. The data, analyzed by ANOVA and Tukey post hoc test, were considered significant for p < 0.05. The results showed behavioral change improvements in the 6-OHDA group, after the treadmill exercise, evaluated by apomorphine rotational behavior, open field, and rota rod tests. The exercise reduced striatal dopaminergic neuronal loss and decreased the oxidative stress. In addition, significant increases in BDNF contents and in immunoreactive cells to TH and DAT were also observed, in striata of the 6-OHDA group with exercise, relatively to those with no exercise. We conclude that exercise improves behavior and dopaminergic neurotransmission in 6-OHDA-lesioned animals. The increased oxidative stress and decreased BDNF contents were also reversed, emphasizing the importance of exercise for the PD management.
- Published
- 2017
- Full Text
- View/download PDF
12. Molecular Epidemiology of Agents of Human Chromoblastomycosis in Brazil with the Description of Two Novel Species.
- Author
-
Gomes RR, Vicente VA, Azevedo CM, Salgado CG, da Silva MB, Queiroz-Telles F, Marques SG, Santos DW, de Andrade TS, Takagi EH, Cruz KS, Fornari G, Hahn RC, Scroferneker ML, Caligine RB, Ramirez-Castrillon M, de Araújo DP, Heidrich D, Colombo AL, and de Hoog GS
- Subjects
- Ascomycota classification, Ascomycota genetics, Brazil epidemiology, Chromoblastomycosis epidemiology, DNA, Fungal genetics, DNA, Ribosomal Spacer genetics, Humans, Molecular Epidemiology, Mycological Typing Techniques, Phylogeny, Ascomycota isolation & purification, Chromoblastomycosis microbiology
- Abstract
The human mutilating disease chromoblastomycosis is caused by melanized members of the order Chaetothyriales. To assess population diversity among 123 clinical strains of agents of the disease in Brazil we applied sequencing of the rDNA internal transcribed spacer region, and partial cell division cycle and β-tubulin genes. Strains studied were limited to three clusters divided over the single family Herpotrichiellaceae known to comprise agents of the disease. A Fonsecaea cluster contained the most important agents, among which F. pedrosoi was prevalent with 80% of the total set of strains, followed by 13% for F. monophora, 3% for F. nubica, and a single isolate of F. pugnacius. Additional agents, among which two novel species, were located among members of the genus Rhinocladiella and Cyphellophora, with frequencies of 3% and 1%, respectively., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2016
- Full Text
- View/download PDF
13. Effect of FGF-2 and sciatic nerve grafting on ChAT expression in dorsal root ganglia neurons of spinal cord transected rats.
- Author
-
Guzen FP, de Araújo DP, Lucena EE, de Morais HH, Cavalcanti JR, do Nascimento ES Jr, Costa MS, and Cavalcante JS
- Subjects
- Animals, Cell Body pathology, Fibroblast Growth Factor 2 metabolism, Male, Neuronal Plasticity, Neurons pathology, Rats, Wistar, Spinal Cord Injuries pathology, Spinal Cord Injuries therapy, Choline O-Acetyltransferase metabolism, Fibroblast Growth Factor 2 pharmacology, Ganglia, Spinal metabolism, Neurons enzymology, Sciatic Nerve transplantation, Spinal Cord Injuries metabolism
- Abstract
Neurotrophic factors and peripheral nerves are known to be good substrates for bridging CNS trauma. The involvement of fibroblast growth factor-2 (FGF-2) activation in the dorsal root ganglion (DRG) was examined following spinal cord injury in the rat. We evaluated whether FGF-2 increases the ability of a sciatic nerve graft to enhance neuronal plasticity, in a gap promoted by complete transection of the spinal cord. The rats were subjected to a 4mm-long gap at low thoracic level and were repaired with saline (Saline or control group, n=10), or fragment of the sciatic nerve (Nerve group, n=10), or fragment of the sciatic nerve to which FGF-2 (Nerve+FGF-2 group, n=10) had been added immediately after lesion. The effects of the FGF-2 and fragment of the sciatic nerve grafts on neuronal plasticity were investigated using choline acetyl transferase (ChAT)-immunoreactivity of neurons in the dorsal root ganglion after 8 weeks. Preservation of the area and diameter of neuronal cell bodies in dorsal root ganglion (DRG) was seen in animals treated with the sciatic nerve, an effect enhanced by the addition of FGF-2. Thus, the addition of exogenous FGF-2 to a sciatic nerve fragment grafted in a gap of the rat spinal cord submitted to complete transection was able to improve neuroprotection in the DRG. The results emphasized that the manipulation of the microenvironment in the wound might amplify the regenerative capacity of peripheral neurons., (Copyright © 2016. Published by Elsevier Ireland Ltd.)
- Published
- 2016
- Full Text
- View/download PDF
14. Central effects of lipoic acid associated with paroxetine in mice.
- Author
-
Silva MC, Sampaio LR, de Araújo DP, Araújo PV, Monte AS, Rodrigues FT, Woods DJ, de Sousa FC, Fonteles MM, and Vasconcelos SM
- Subjects
- Animals, Anti-Anxiety Agents administration & dosage, Anti-Anxiety Agents pharmacology, Antidepressive Agents administration & dosage, Anxiety drug therapy, Depression drug therapy, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Therapy, Combination, Male, Mice, Motor Activity drug effects, Paroxetine administration & dosage, Selective Serotonin Reuptake Inhibitors administration & dosage, Selective Serotonin Reuptake Inhibitors pharmacology, Thioctic Acid administration & dosage, Antidepressive Agents pharmacology, Behavior, Animal drug effects, Paroxetine pharmacology, Thioctic Acid pharmacology
- Abstract
Antidepressants, including selective serotonin reuptake inhibitors, are commonly prescribed for the treatment of affective disorders such as anxiety and depression. The purpose of this study was to investigate the central effects of acute administration of paroxetine (PXT) combined with lipoic acid (LA) on various behavioral models in mice. Paroxetine (10 and 20 mg/kg), LA (100 mg/kg), or vehicle was administered, intraperitoneally, 30 minutes before the tests. The results showed that PXT (10 mg/kg) alone and in combination with LA increased locomotor activity. In the anxiety models studied, an anxiolytic effect was observed after the administration of LA and PXT. In the tail suspension test, PXT at both doses and in combination with LA caused a significant decrease in immobility time. These results indicate possible anxiolytic and antidepressant effects of LA associated with PXT. These data suggest that coadministration of LA and PXT may improve anxiolytic and antidepressant responses, and being more effective than each drug alone. However, further studies are necessary to investigate the mechanism by which antioxidants exert antidepressant or anxiolytic action.
- Published
- 2014
- Full Text
- View/download PDF
15. Behavioral and neurochemical effects of alpha-lipoic Acid in the model of Parkinson's disease induced by unilateral stereotaxic injection of 6-ohda in rat.
- Author
-
de Araújo DP, De Sousa CN, Araújo PV, Menezes CE, Sousa Rodrigues FT, Escudeiro SS, Lima NB, Patrocínio MC, Aguiar LM, Viana GS, and Vasconcelos SM
- Abstract
This study aimed to investigate behavioral and neurochemical effects of α -lipoic acid (100 mg/kg or 200 mg/kg) alone or associated with L-DOPA using an animal model of Parkinson's disease induced by stereotaxic injection of 6-hydroxydopamine (6-OHDA) in rat striatum. Motor behavior was assessed by monitoring body rotations induced by apomorphine, open field test and cylinder test. Oxidative stress was accessed by determination of lipid peroxidation using the TBARS method, concentration of nitrite and evaluation of catalase activity. α -Lipoic acid decreased body rotations induced by apomorphine, as well as caused an improvement in motor performance by increasing locomotor activity in the open field test and use of contralateral paw (in the opposite side of the lesion produced by 6-OHDA) at cylinder test. α -lipoic acid showed antioxidant effects, decreasing lipid peroxidation and nitrite levels and interacting with antioxidant system by decreasing of endogenous catalase activity. Therefore, α -lipoic acid prevented the damage induced by 6-OHDA or by chronic use of L-DOPA in dopaminergic neurons, suggesting that α -lipoic could be a new therapeutic target for Parkinson's disease prevention and treatment.
- Published
- 2013
- Full Text
- View/download PDF
16. [Comprehensive health care as the core concept for technological organization in services].
- Author
-
Bonfada D, Cavalcante JR, de Araújo DP, and Guimarães J
- Subjects
- Brazil, Humans, Comprehensive Health Care, Delivery of Health Care organization & administration
- Abstract
Despite the marked achievements of the Unified Health System (SUS), implementation of its principles and guidelines has not yet been fully achieved. Therefore, this article reflects on comprehensiveness and technology reorganization based on soft technologies and expanded clinical care, not only as guidelines, but as core elements for a new way of thinking about health. It involves a literature review that not only seeks an overview of ideas about the subject, but also attempts to establish a dialogue between the authors in reference to reflect on daily services, especially in hospital. We found that most of the obstacles to improvement of the services of the SUS are related to the predominance of curative medical care in the thinking process of health professionals. Breaking with that logic, comprehensive care, technological reorganization and expanded clinical care can foster closer approximation between professionals and users, at the same time as actions come to be dictated by the individuals and the community, breaking with the vertical imposition of conduct. Thus, the traditional 'biologicist' approach to clinical care needs to be deconstructed to break with the logic of manifest suffering and "treat 'em and street 'em" philosophy.
- Published
- 2012
- Full Text
- View/download PDF
17. The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review.
- Author
-
De Araújo DP, Lobato Rde F, Cavalcanti JR, Sampaio LR, Araújo PV, Silva MC, Neves KR, Fonteles MM, Sousa FC, and Vasconcelos SM
- Subjects
- Animals, Antioxidants pharmacology, Apoptosis drug effects, Disease Progression, Humans, Oxidative Stress drug effects, Reactive Oxygen Species metabolism, Thioctic Acid pharmacokinetics, Thioctic Acid pharmacology, Antioxidants therapeutic use, Nerve Degeneration drug therapy, Parkinson Disease drug therapy, Parkinson Disease pathology, Thioctic Acid therapeutic use
- Abstract
ABSTRACT This work reviews the evidence of the mechanism of neuronal degeneration in Parkinson's disease (PD) and the neuroprotective effect of lipoic acid and its use in the treatment of PD. PD is characterized by slow and progressive degeneration of dopaminergic neurons of the substantia nigra pars compacta, leading to reduction of the striatal dopaminergic terminals. It is known that several factors influence neuronal damage. Among these factors, oxidative stress, immune system activity, microglial cells, and apoptotic mechanisms are of major importance. Currently, several antioxidants have been studied with the aim of reducing/slowing the progression of neurodegenerative processes. Lipoic acid is considered a universal antioxidant because it is an amphipathic substance. Lipoic acid and its reduced form, dihidrolipoic acid, act against reactive oxygen species, reducing oxidative stress. Therefore, this antioxidant has been used in the treatment of many diseases, including a new perspective for the treatment of Parkinson's disease.
- Published
- 2011
- Full Text
- View/download PDF
18. Experimental therapy of epilepsy with transcranial magnetic stimulation: lack of additional benefit with prolonged treatment.
- Author
-
Brasil-Neto JP, de Araújo DP, Teixeira WA, Araújo VP, and Boechat-Barros R
- Subjects
- Adult, Child, Electric Stimulation, Electroencephalography, Female, Humans, Male, Middle Aged, Time Factors, Treatment Outcome, Epilepsy therapy, Transcranial Magnetic Stimulation therapeutic use
- Abstract
Objective: To investigate the effect of three months of low-frequency repetitive transcranial magnetic stimulation (rTMS) treatment in intractable epilepsy., Methods: Five patients (four males, one female; ages 6 to 50 years), were enrolled in the study; their epilepsy could not be controlled by medical treatment and surgery was not indicated. rTMS was performed twice a week for three months; patients kept records of seizure frequency for an equal period of time before, during, and after rTMS sessions. rTMS was delivered to the vertex with a round coil, at an intensity 5% below motor threshold. During rTMS sessions, 100 stimuli (five series of 20 stimuli, with one-minute intervals between series) were delivered at a frequency of 0.3 Hz., Results: Mean daily number of seizures (MDNS) decreased in three patients and increased in two during rTMS--one of these was treated for only one month; the best result was achieved in a patient with focal cortical dysplasia (reduction of 43.09% in MDNS). In the whole patient group, there was a significant (p<0.01) decrease in MDNS of 22.8%., Conclusion: Although prolonged rTMS treatment is safe and moderately decreases MDNS in a group of patients with intractable epilepsy, individual patient responses were mostly subtle and clinical relevance of this method is probably low. Our data suggest, however, that patients with focal cortical lesions may indeed benefit from this novel treatment. Further studies should concentrate on that patient subgroup.
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.